148 related articles for article (PubMed ID: 30772478)
1. Trends in Asthma Control, Treatment, Health Care Utilization, and Expenditures Among Children in the United States by Place of Residence: 2003-2014.
Sullivan PW; Ghushchyan V; Kavati A; Navaratnam P; Friedman HS; Ortiz B
J Allergy Clin Immunol Pract; 2019; 7(6):1835-1842.e2. PubMed ID: 30772478
[TBL] [Abstract][Full Text] [Related]
2. Health Disparities Among Children with Asthma in the United States by Place of Residence.
Sullivan PW; Ghushchyan V; Kavati A; Navaratnam P; Friedman HS; Ortiz B
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):148-155. PubMed ID: 29782937
[TBL] [Abstract][Full Text] [Related]
3. National Prevalence of Poor Asthma Control and Associated Outcomes Among School-Aged Children in the United States.
Sullivan PW; Ghushchyan V; Navaratnam P; Friedman HS; Kavati A; Ortiz B; Lanier B
J Allergy Clin Immunol Pract; 2018; 6(2):536-544.e1. PubMed ID: 28847656
[TBL] [Abstract][Full Text] [Related]
4. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
6. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
[TBL] [Abstract][Full Text] [Related]
7. Prescription fill patterns in underserved children with asthma receiving subspecialty care.
Bollinger ME; Mudd KE; Boldt A; Hsu VD; Tsoukleris MG; Butz AM
Ann Allergy Asthma Immunol; 2013 Sep; 111(3):185-9. PubMed ID: 23987193
[TBL] [Abstract][Full Text] [Related]
8. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
Griffiths B; Ducharme FM
Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilization in infants and toddlers with asthma-like symptoms.
Levine H; Leventer-Roberts M; Hoshen M; Mei-Zahav M; Balicer R; Blau H
Pediatr Pulmonol; 2019 Oct; 54(10):1567-1577. PubMed ID: 31298808
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
Dasgupta R; Guest JF
Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
[TBL] [Abstract][Full Text] [Related]
11. Profile of children requiring emergency treatment for asthma.
Friday GA; Khine H; Lin MS; Caliguiri LA
Ann Allergy Asthma Immunol; 1997 Feb; 78(2):221-4. PubMed ID: 9048532
[TBL] [Abstract][Full Text] [Related]
12. Comparative safety and costs of stepping down asthma medications in patients with controlled asthma.
Rank MA; Liesinger JT; Branda ME; Gionfriddo MR; Schatz M; Zeiger RS; Shah ND
J Allergy Clin Immunol; 2016 May; 137(5):1373-1379.e3. PubMed ID: 26506020
[TBL] [Abstract][Full Text] [Related]
13. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
[TBL] [Abstract][Full Text] [Related]
16. Examining asthma quality of care using a population-based approach.
Klomp H; Lawson JA; Cockcroft DW; Chan BT; Cascagnette P; Gander L; Jorgenson D
CMAJ; 2008 Apr; 178(8):1013-21. PubMed ID: 18390944
[TBL] [Abstract][Full Text] [Related]
17. Cessation of long-acting β2-agonist in children with persistent asthma on inhaled corticosteroids.
Ducharme FM; Gagnon R; Bénard B; Tse SM; Thivierge R
Eur Respir J; 2016 Aug; 48(2):558-60. PubMed ID: 27230440
[No Abstract] [Full Text] [Related]
18. Long-term management of asthma in children: effectiveness of inhaled corticosteroids compared to other medications.
National Asthma Education and Prevention Program
J Allergy Clin Immunol; 2002 Nov; 110(5 Suppl):S147-60. PubMed ID: 12518556
[No Abstract] [Full Text] [Related]
19. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children.
Warman KL; Silver EJ; Stein RE
Pediatrics; 2001 Aug; 108(2):277-82. PubMed ID: 11483788
[TBL] [Abstract][Full Text] [Related]
20. The national cost of asthma among school-aged children in the United States.
Sullivan PW; Ghushchyan V; Navaratnam P; Friedman HS; Kavati A; Ortiz B; Lanier B
Ann Allergy Asthma Immunol; 2017 Sep; 119(3):246-252.e1. PubMed ID: 28890020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
